• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病中肺动脉高压与实验室参数的相关性——一项回顾性研究

Correlation of Pulmonary Arterial Hypertension with Laboratory Parameters in Sickle Cell Disease- A Retrospective Study.

作者信息

Paul Anindita, Samal Priyanka, Behera Kumar Gaurav, Patra Pritish Chandra, Samal Ashutosh, Bishoyi Ajit Kumar, Pradhan Sarita

机构信息

Department of Clinical Hematology, Institute of Medical Sciences & Sum Hospital, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, Odisha 751003 India.

Department of Cardiology, Institute of Medical Sciences & Sum Hospital, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, Odisha 751003 India.

出版信息

Indian J Hematol Blood Transfus. 2025 Apr;41(2):377-382. doi: 10.1007/s12288-024-01772-4. Epub 2024 May 8.

DOI:10.1007/s12288-024-01772-4
PMID:40224697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11992314/
Abstract

To study the prevalence of pulmonary arterial hypertension (PAH) in individuals with sickle cell disease (SCD) and its relationship with serological markers. Data of ninety-two SCD patients who visited the Department of Clinical Haematology between 2020 and 2021 was retrieved through the hospital record system. These patients underwent laboratory testing, including a clinical evaluation was done at baseline. They underwent Doppler echocardiography to determine the maximum tricuspid regurgitation jet velocity. Among 92 patients, 43 were men and 49 were female, with the mean age being 29.9 ± 8.8 years. Using Doppler echocardiography, their pulmonary artery systolic pressure was determined. Pulmonary arterial hypertension was found in 29 out of 92 patients (31.5%). The prevalence of PAH was 20.9% in males and 40.8% in women. A significant association was shown with females (p = 0.041.) There was a positive correlation with hemolytic markers, including reticulocyte count (r = 0.212, p < 0.05), lactate dehydrogenase (r = 0.322, p < 0.01 with tricuspid regurgitation velocity (TRvmax) (r = 0.322, p < 0.01) along with NT-ProBNP (r = 0.310, p < 0.01). The maximal tricuspid regurgitation velocity and haemoglobin concentration had a negative correlation. (r = -0.340, p < 0.01). In resource-limited settings, NT Pro BNP and transthoracic echocardiography can be used as screening tools for pulmonary hypertension in SCD.

摘要

研究镰状细胞病(SCD)患者中肺动脉高压(PAH)的患病率及其与血清学标志物的关系。通过医院记录系统检索了2020年至2021年间到临床血液科就诊的92例SCD患者的数据。这些患者接受了实验室检查,包括在基线时进行临床评估。他们接受了多普勒超声心动图检查以确定三尖瓣反流最大射流速度。92例患者中,男性43例,女性49例,平均年龄为29.9±8.8岁。使用多普勒超声心动图测定他们的肺动脉收缩压。92例患者中有29例(31.5%)发现患有肺动脉高压。PAH在男性中的患病率为20.9%,在女性中的患病率为40.8%。女性显示出显著相关性(p = 0.041)。与溶血标志物存在正相关,包括网织红细胞计数(r = 0.212,p < 0.05)、乳酸脱氢酶(r = 0.322,p < 0.01),与三尖瓣反流速度(TRvmax)(r = 0.322,p < 0.01)以及N末端B型钠尿肽原(r = 0.310,p < 0.01)。三尖瓣反流最大速度与血红蛋白浓度呈负相关(r = -0.340,p < 0.01)。在资源有限的环境中,N末端B型钠尿肽原和经胸超声心动图可作为SCD患者肺动脉高压的筛查工具。

相似文献

1
Correlation of Pulmonary Arterial Hypertension with Laboratory Parameters in Sickle Cell Disease- A Retrospective Study.镰状细胞病中肺动脉高压与实验室参数的相关性——一项回顾性研究
Indian J Hematol Blood Transfus. 2025 Apr;41(2):377-382. doi: 10.1007/s12288-024-01772-4. Epub 2024 May 8.
2
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: An Australian prospective cross-sectional study.N 端前脑钠肽与系统性硬化症患者的肺动脉高压或舒张功能障碍相关:一项澳大利亚前瞻性横断面研究。
J Scleroderma Relat Disord. 2024 Oct;9(3):178-184. doi: 10.1177/23971983241249209. Epub 2024 May 9.
5
Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.脑利钠肽和 N 末端脑利钠肽在诊断早产儿血液动力学意义未闭动脉导管中的应用。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013129. doi: 10.1002/14651858.CD013129.pub2.
6
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.孕早期单独进行超声检查或与孕早期血清检查联合用于唐氏综合征筛查。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012600. doi: 10.1002/14651858.CD012600.
7
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
8
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
9
Inhaled nitric oxide for treating pain crises in people with sickle cell disease.吸入一氧化氮治疗镰状细胞病患者的疼痛危象。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD011808. doi: 10.1002/14651858.CD011808.pub3.
10
The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.儿童镰状细胞病的一级卒中预防的临床效果和成本效益:系统评价和经济评估。
Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430.

本文引用的文献

1
Hemodynamic predictors of mortality in adults with sickle cell disease.镰状细胞病成人死亡的血流动力学预测因素。
Am J Respir Crit Care Med. 2013 Apr 15;187(8):840-7. doi: 10.1164/rccm.201207-1222OC.
2
NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa.NT-proBNP 作为非洲镰状细胞贫血中心肺状态的标志物。
Br J Haematol. 2010 Jul;150(1):102-7. doi: 10.1111/j.1365-2141.2010.08195.x. Epub 2010 Apr 16.
3
Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.在评估患有肺动脉高压的镰状细胞病儿童和年轻成人中,三尖瓣反流喷射速度与溶血相关。
Haematologica. 2007 Nov;92(11):1549-52. doi: 10.3324/haematol.11576.
4
Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.镰状细胞/β地中海贫血患者的肺动脉高压:发病率及其与血清N末端脑钠肽前体浓度的相关性
Haematologica. 2007 Jun;92(6):738-43. doi: 10.3324/haematol.11136.
5
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.镰状细胞病合并肺动脉高压患者的血流动力学和功能评估
Am J Respir Crit Care Med. 2007 Jun 15;175(12):1272-9. doi: 10.1164/rccm.200610-1498OC. Epub 2007 Mar 22.
6
N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.镰状细胞病中N末端前脑钠肽水平与死亡风险
JAMA. 2006 Jul 19;296(3):310-8. doi: 10.1001/jama.296.3.310.
7
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.由去分隔的氧合血红蛋白加速一氧化氮失活介导的溶血相关内皮功能障碍。
J Clin Invest. 2005 Dec;115(12):3409-17. doi: 10.1172/JCI25040. Epub 2005 Nov 17.
8
Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.脑钠肽与肺纤维化和肺动脉高压患者的运动能力
Am J Respir Crit Care Med. 2004 Aug 15;170(4):360-5. doi: 10.1164/rccm.200308-1142OC. Epub 2004 Apr 15.
9
Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.脑钠肽在原发性肺动脉高压中的临床意义
J Am Coll Cardiol. 2004 Mar 3;43(5):764-70. doi: 10.1016/j.jacc.2003.09.051.
10
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.肺动脉高压作为镰状细胞病患者死亡的一个危险因素。
N Engl J Med. 2004 Feb 26;350(9):886-95. doi: 10.1056/NEJMoa035477.